Join to View Full Profile
9300 Campus Point DrLa Jolla, CA 92037
Phone+1 858-534-4848
Join Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Monika Kumaraswamy, MD is an infectious disease specialist in La Jolla, California. She is currently licensed to practice medicine in California, Texas, and Ohio.
Education & Training
University of California (San Diego) Medical CenterFellowship, Infectious Disease, 2012 - 2015
Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Internal Medicine, 2009 - 2012
Medical College of WisconsinClass of 2009- Medical College of WisconsinClass of 2009
Certifications & Licensure
TX State Medical License 2024 - 2026
CA State Medical License 2012 - 2025
OH State Medical License 2009 - 2012
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Infectious Disease
Publications & Presentations
PubMed
- 3 citationsComprehensive stability analysis of 13 β-lactams and β-lactamase inhibitors inmedia, and novel supplement dosing strategy to mitigate thermal drug degradation.Jieqiang Zhou, Yuli Qian, Yinzhi Lang, Yongzhen Zhang, Xun Tao
Antimicrobial Agents and Chemotherapy. 2024-03-06 - 6 citationsImproved characterization of aminoglycoside penetration into human lung epithelial lining fluid via population pharmacokinetics.Eunjeong Shin, Yongzhen Zhang, Jieqiang Zhou, Yinzhi Lang, Alaa R M Sayed
Antimicrobial Agents and Chemotherapy. 2024-02-07 - Unrecognized Potent Activities of Colistin Against Clinically Important+ Enterobacteriaceae Revealed in Synergy with Host Immunity.Monika Kumaraswamy, Angelica Riestra, Anabel Flores, Satoshi Uchiyama, Samira Dahesh
Biorxiv. 2023-03-21
Authored Content
- 'Listeria Monocytogenes Endocarditis: Case Report, Review of the Literature,January 2018
Press Mentions
Researchers Turn Powerful, Viscous Disinfectants into Mist for the First TimeAugust 1st, 2018
Grant Support
- Surprising Efficacy of Discounted Antibiotics vs. MDR Gram-Negative Pathogens Occurring Through Innate Immune SensitizationUNIVERSITY OF CALIFORNIA, SAN DIEGO2020–2025
